ACAltug Cincin

Altug Cincin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Altug Cincin has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevention of Vascular Calcification via Fetuin-Modified Bioprosthetic Implants: Insights from in Vitro Models

    by Paulina Piotrowska, Ankit Mazumdar, Natalia Beshchasna, Bjoern Guenther, Roman Viter, Mindaugas Tamošiūnas, Iryna Tepliakova, Özlem Saröz Kirazli, Ahmet Altuğ Çinçin, Esin Ak, et al.

    Research into bioprosthetic heart valve (BHV) materials seeks to enhance durability and biocompatibility, particularly by mitigating vascular calcification (VC). VC entails hydroxyapatite deposition in blood vessel walls through vascular smooth muscle cells (VSMCs) phenotypic switching to osteogenic differentiation, driven by pro-calcific signals that might be inhibited by fetuin-A. To our knowledge, no prior studies have reported fetuin-coated bovine vein tissue for this purpose. This study aimed to evaluate the cytotoxicity, biocompatibility, and anti-calcification potential of fetuin-coated biomaterial. The effectiveness of fetuin coating on biomaterial was characterized using photoluminescence (PL), FTIR and Raman spectroscopy, while fetuin release was quantified. Biocompatibility was evaluated in vitro on VSMCs and human iliac artery endothelial cells (HIAE-78T) and in vivo by subcutaneous implantation in Wistar rats. The effects of fetuin were investigated in two in vitro calcification models based on 2 mM inorganic phosphate, or 10 mM β-glycerophosphate in an organic model. The induction of osteogenic markers such as osterix, bone morphogenic protein 2, and collagen type 1, osteocalcin and osteopontin, was assessed at both the mRNA and protein levels. Detoxification of glutaraldehyde-fixed biomaterial using glycine and NaBH₄ eliminated cytotoxicity, markedly enhancing biocompatibility toward VSMCs, HIAE-78T and subcutaneous rat implants, which showed no acute rejection and preserved structural integrity. Fetuin coating, with ~30% sustained release over three weeks, significantly inhibited mineralization on non-cellular and organic VSMCs models by decreasing mineral deposition, osteogenic markers expression. These results position fetuin-coated bovine vein biomaterial as a novel, promising anti-calcification strategy enhancing long-term durability and cardiac valves safety.

  • The effect of influenza vaccine on arterial stiffness in young healthy adults

    by Ümit Öztürk, Murat Sünbül, Baran Ertürk, Barış Kaya, Derya Parlatan, Ezgi Doğruyol, Zeynep Ebrar Acar, Elif Tükenmez Tigen, Ahmet Altuğ Çinçi, Emre Gürel, et al.

    Objective: The arterial wall possesses a complex structure. Over time, arteries lose elasticity and become stiffer due to factors such as aging, chronic diseases, and increased inflammation. Pulse wave velocity (PWV) and augmentation index (AI) are widely recognized as direct markers of arterial stiffness. Previous studies have suggested a link between seasonal influenza infection and increased cardiovascular mortality. This study aimed to investigate the effects of influenza vaccination on arterial stiffness in healthy young adults. Patients and Methods: The study enrolled participants who received the influenza vaccine according to the latest guidelines. Prior to vaccination, participants completed the Hospital Anxiety and Depression Scale (HADS) to assess baseline mood and anxiety levels. Arterial stiffness was measured using an oscillometric device. After a 15-day follow-up, HADS assessments and arterial stiffness measurements were repeated. Results: A total of 48 participants were initially enrolled, and 33 who completed the follow-up were included in the final analysis. Statistically significant reductions were observed in systolic blood pressure (p

  • Open Access

    Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission

    by Gökhan Tazegül, Volkan Aydın, Elif Tükenmez Tigen, Buket Erturk Sengel, Kübra Köksal, Buket Doğan, Sait Karakurt, Zehra Aysun Altıkardeş, Lütfiye Mülazimoğlu, Ali Serdar Fak, et al.

    Background: Herein, we aimed to develop and test machine learning (ML) models to predict disease severity and/or progression in hospitalized COVID-19 patients through baseline laboratory features. Methods: In this retrospective study of hospitalized COVID-19 patients admitted to a tertiary care center, we evaluated routine admission data to determine the accuracy rates of different ML algorithms: k-nearest neighbor classifier, bagging classifier, random forest (RF), and decision tree. These models were compared over three outcomes: those who needed oxygen supplementation vs. who did not on admission (Analysis 1, n: 180), those who later developed oxygen requirement vs. those who did not (Analysis 2, n: 112), and those who needed invasive mechanical ventilation vs. those who did not during hospitalization (Analysis 3, n: 164). Results: The median age of the patients was 55 (44-68) years, with males constituting 47.2% of the subjects. At admission, 37.8% of the patients required oxygen supplementation. During hospitalization, 17.5% needed mechanical ventilation, and 8.3% died. For all analyses, RF had the highest accuracy in classifying the need for oxygen supplementation on admission (89.4%) or during hospitalization (91.1%) and for invasive mechanical ventilation (92.2%). These were followed by a bagging classifier for Analysis 1 (88.3%) and Analysis 3 (91.0%) and by a decision tree for Analysis 2 (88.4%). C-reactive protein, monocyte distribution width, and high-sensitive troponin-T were the most crucial laboratory contributors to Analysis 1, Analysis 2, and Analysis 3, respectively. Conclusion: Our study showed that ML algorithms could predict the need for oxygen supplementation and mechanical ventilation during hospitalization using baseline laboratory data, suggesting a slight superiority of RF, among others.

  • The effect of cardiac rehabilitation on left ventricular diastolic functions assessed by exercise stress echocardiography in patients with acute coronary syndrome

    by Fatih Besıroglu, Murat Sunbul, Beste Ozben, Ilker Yagcı, Jeyhun Mammadov, Nurten Sayar, Altug Cıncın, Kursat Tıgen, Osman Yesıldag, Yelda Basaran

    Objective: The aim of our study is to investigate the impact of cardiac rehabilitation on left ventricular (LV) diastolic function in acute coronary syndrome (ACS) patients. Patients and Methods: Patients were selected consecutively among ACS patients who underwent primary percutaneous intervention and were found eligible for cardiac rehabilitation program from May 2014 to May 2015. Forty-four patients were included in cardiac rehabilitation group and recruited to 30 sessions of Phase-3 cardiac rehabilitation program six weeks after discharge. Twenty consecutive patients were included as control group. LV diastolic functions were assessed by resting and stress echocardiography. Results: There were not any significant differences in characteristics between the groups. Resting and stress E velocities and resting lateral e’ velocity significantly increased after rehabilitation program. Left atrial volume index, resting and stress A velocities and average E/e’ ratios were significantly lower while stress lateral e’ velocity was significantly higher in rehabilitation group after program compared to controls. The number of patients with diastolic dysfunction decreased after rehabilitation program. Final resting and stress echocardiography revealed significantly lower frequency of diastolic dysfunction in rehabilitation group. Conclusion: Cardiac rehabilitation improves diastolic functions in ACS patients, which may be detected by stress echocardiography.


  • Open Access

    The Impact of Cystic Fibrosis- and Noncystic Fibrosis-Bronchiectasis on Pulmonary Artery Wall Thickness and Right Heart Functions Assessed by Speckle-Tracking Echocardiography

    by Emre Gürel, Duygu Vezir, Tuba Güçtekin, Zekeriya Doğan, Derya Kocakaya, Sehnaz Olgun, Murat Sünbül, Altuğ Çinçin, Beste Özben, Nurten Sayar, et al.

    Right heart functions are affected in patients with bronchiectasis as a result of pulmonary hypertension induced by chronic hypoxemia. Pulmonary artery wall thickness has recently been introduced as a sign of intensive and prolonged inflammation. The aim of this study was to analyze right ventricular and right atrial functions and to mea-sure pulmonary artery wall thickness in patients with cystic fibrosis-bronch iecta sis in comparison to those with noncystic fibrosis-bronchiectasis and healthy individuals. We studied 36 patients with cystic fibrosis-bronchiectasis, 34 patients with noncystic fibrosis-bronchiectasis, and 32 age- and sex-matched control subjects. Lung function tests were performed. All subjects underwent comprehensive echocardiographic evaluation including conventional, tissue Doppler, speckle-tracking, and pulmonary artery wall thickness measurements. Right ventricular global longitudinal strain and global longitudinal right atrial strain during ventricular systole decreased in cystic fibrosis-bronchiectasis group compared with noncystic fibrosis-bronchiectasis and control groups (P <.001, both). Conversely, pulmonary artery wall thickness was increased in cystic fibrosis-bronchiectasis group in comparison to other groups (P <.001). Moreover, right ventricular global longitudinal strain was lower and pulmonary artery wall thickness was higher in patients with airflow obstruction (P <.001 and P =.025, respectively) than in those without. Only right ventricular global longitudinal strain was significantly correlated with pulmonary function test parameters. The negative effect of cystic fibrosis on right ventricular and right atrial functions was independent of age, gender, and disease duration. Our study showed that right ventricular and right atrial functions were deteriorated and pulmonary artery wall was thickened in cystic fibrosis-bronchiectasis patients more than noncystic fibrosis-bronchiectasis patients. Right ventricular global longitudinal strain detected subclinical right ventricular dysfunction and was associated with the severity of pulmonary disease.


  • Open Access

    Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data

    by Mustafa Kürşat Tigen, Mehmet Hasan Özdil, Altuğ Çinçin, Emre Gürel, Murat Sünbül, Anıl Şahin, Tuba Güçtekin, Zekeriya Doğan, Nurten Sayar, Beste Özben

    Combination of dual antiplatelet therapy (DAPT) with glycoprotein (GP) IIb/IIIa inhibitors can increase bleeding risk. In this study, we aimed to investigate bleeding complications of different DAPTs with concomitant tirofiban use in patients with acute coronary syndrome (ACS). This retrospective study included 224 consecutive ACS patients (mean age 56.6±11.1 years, 193 men) who were given conventional dose of tirofiban (25 μg/kg per 3 minutes followed by an infusion of 0.15 μg/kg/min for 24 hours) in addition to DAPT (300 mg aspirin followed by 100 mg/day + 600 mg clopidogrel followed by 75 mg/day or 180 mg ticagrelor followed by 90 mg twice daily or 60 mg prasugrel followed by 10 mg/day). Any intra-hospital bleeding complications were noted. Of the 224 patients, 115 were given ticagrelor and 32 were given prasugrel. Mean hemoglobin fall was similar between the patients taking ticagrelor/prasugrel and those taking clopidogrel. Ten patients taking ticagrelor and one patient taking prasugrel had hemoglobin fall ≥3 g/dL versus two patients in clopidogrel group (p=0.228). Gastrointestinal bleeding (two patients taking ticagrelor), hematoma at access site (three patients taking ticagrelor), and cardiac tamponade (two patients taking ticagrelor) rates were also similar. Creatinine levels were associated with hemoglobin fall ≥3 g/dL (p=0.032, Odds ratio 2.189, 95% confidence interval 1.070–4.479). There was no relation between hemoglobin fall ≥3 g/dL and antiplatelet agent, age, sex, hypertension, or diabetes. Tirofiban may be given to patients receiving ticagrelor or prasugrel with a bleeding rate similar to clopidogrel. Close monitoring for bleeding risk is recommended, especially in patients with higher creatinine levels.


  • Subacute aortic prosthetic mechanical valve thrombosis complicated with acute coronary syndrome

    by Batur Gonenc Kanar, Kursat Tigen, Halil Atas, Altug Cincin, Beste Ozben


  • Open Access

    The impact of right ventricular function assessed by 2‐dimensional speckle tracking echocardiography on early mortality in patients with inferior myocardial infarction

    by Batur G. Kanar, Mustafa K. Tigen, Murat Sunbul, Altug Cincin, Halil Atas, Alper Kepez, Beste Ozben

    Background: Right ventricular (RV) involvement in inferior myocardial infarction (MI) increases in‐hospital morbidity and mortality.Hypothesis: RV systolic dysfunction assessed by 2‐dimensional speckle tracking echocardiography (STE) might be a predictor of early mortality in patients with acute inferior MI.Methods: Eighty‐one consecutive patients with acute inferior MI (mean age, 60.8 ± 12.7 years; 18 females) were included. RV myocardial involvement was defined as an elevation >1 mm in V1 or V4R within 12 hours of symptom onset. RV function was assessed by STE. Patients were followed for 30 days for all‐cause mortality.Results: Thirty‐eight patients had RV myocardial involvement, and they had significantly lower tricuspid annular plane systolic excursion (TAPSE), tricuspid annular systolic velocity (RVS), and left ventricular (LV) and RV global longitudinal strain (GLS). Nine patients (11%) died within 30 days. The mean age of mortality group was higher with more female frequency. They had significantly higher pro‐BNP, hs‐troponin T, and creatinine levels, but lower hemoglobin levels. TIMI 3 flow was significantly less achieved in mortality group. RV myocardial involvement was more frequent in the mortality group, and they had significantly lower TAPSE, RVS, and LV and RV GLS. Multivariate analysis revealed that age and RV GLS were independent predictors of early mortality. RV GLS ≤ –14% predicted early mortality in patients with acute inferior MI with a sensitivity of 88.9% and a specificity of 62.5% (AUC: 0.817, P = 0.002).Conclusions: RV GLS may be useful in predicting early mortality in patients with acute inferior MI.


  • Effect of vitamin D deficiency and supplementation on myocardial deformation parameters and epicardial fat thickness in patients free of cardiovascular risk

    by Murat Sunbul, Mehmet Bozbay, Ceyhun Mammadov, Altug Cincin, Halil Atas, Ekmel Burak Ozsenel, Ibrahim Sari, Yelda Basaran

    Vitamin D deficiency is associated with impaired myocardial deformation parameters and cardiovascular disease (CVD). Increased epicardial fat thickness (EFT) is also associated with increased risk of CVD. The aim of the study is to evaluate the effect of vitamin D deficiency and supplementation on myocardial deformation parameters and EFT. The study population consisted of 50 patients with vitamin D deficiency who were free of cardiovascular risk (mean age: 42.6 ± 8.9 years, 37 female). Patients were treated with oral administration of vitamin D3. Myocardial deformation parameters and EFT were evaluated before and after treatment of those patients. Vitamin D levels significantly increased after treatment (30.5 ± 10.5 vs. 9.9 ± 5.3 nmol/l, p < 0.001). There was no significant difference between conventional echocardiographic parameters before and after treatment. Baseline EFT was significantly higher than post-treatment measurements (35.2 ± 8.0 vs. 27.5 ± 5.6 mm, p < 0.001). Post-treatment myocardial deformation parameters were also significantly higher than baseline measurements. Baseline vitamin D levels correlated with baseline EFT and left ventricular global longitudinal strain (LV-GLS). Post-treatment vitamin D levels also correlated with post-treatment EFT, body mass index, and LV-GLS. Baseline vitamin D level was an independent predictor of baseline LV-GLS (p = 0.002). Patients with impaired LV-GLS had significantly lower vitamin D levels than patients with normal LV-GLS (6.6 ± 3.8 vs. 11.0 ± 5.3 nmol/l, p = 0.005). Baseline vitamin D level was also an independent predictor of baseline impaired LV-GLS (p = 0.010). Vitamin D supplementation has beneficial effects on myocardial deformation parameters and EFT. Moreover, baseline vitamin D levels are a predictor of impaired LV-GLS.


  • A pedunculated left ventricular hemangioma initially misdiagnosed as thrombus in a woman with atypical chest pain

    by M. Azra Tanrikulu, Beste Ozben, A. Altug Cincin, Ozdil Baskan, Mehmet Agirbasli

    The incidence of cardiac masses increased as echocardiography is becoming increasingly popular. Benign tumors of the heart constitute about 72% of all primary cardiac neoplasms and hemangioma accounts for 5–10% of benign cardiac tumors. Cardiac hemangiomas are generally asymptomatic and diagnosed incidentally during echocardiography or magnetic resonance imaging (MRI). We reported a 52-year-old woman presented with atypical chest pain and exertional dyspnea. The echocardiographic examination revealed a hyperechoic round mass in the left ventricle. With an initial diagnosis of left ventricular thrombus, the patient underwent cardiac MRI. The mass was found compatible with cardiac hemangioma. It was removed surgically and histopathologic evaluation identified a cardiac hemangioma. As reports of cardiac hemangioma are extremely rare and cardiac masses are mostly thought to be thrombi or myxomas (being the most common primary cardiac tumor), such hemangioma cases warrant attention as possibility of hemangioma should also be kept in mind.